News

F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment

July 13, 2017/

A Food and Drug Administration panel opened a new era in medicine on Wednesday, unanimously recommending that the agency approve the first-ever treatment that genetically alters a patient’s own cells to fight cancer, transforming them into what scientists call "a living drug" that powerfully bolsters the immune system to shut down the disease.

By DENISE GRADY

Full Story: https://www.nytimes.com/2017/07/12/health/fda-novartis-leukemia-gene-medicine.html?emc=edit_na_20170712&nl=breaking-news&nlid=34889205&ref=headline

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

MATR Sponsor (view all)


"For small to medium to national organizations, for events and fundraisers of any size, in any format – live, virtual or hybrid – the platform is built for scale."

MATR Supporters (view all)


We will bring the North Coast Hiawatha train route back to Southern Montana

Working closely with GFDA’s economic development team, HPF helps Montana businesses access the capital they need to expand, modernize, and strengthen local communities.

ADROIT Employer Resources is a Montana-based workforce and talent solutions partner